Notably, using the same breast cancer TMA as in this study, GRN expression was found to correlate with the same clinicopathological features as CD163+ macrophages in TS [15] as well as with the density of CD163+ macrophages in TS. The gene discussed is CD163; the disease is breast carcinoma.